The Fair Credit Billing Act: Key Insights and Practical Tips — FCRA Focus Podcast
The Biden Administration's Push for Transparency in AI Technology
ChatGPT Risks for Compliance Programs
Digital Planning Podcast Episode: Understanding Biometrics and the Impact on Estate Planning
Recent Trends in Article III Standing - The Consumer Finance Podcast
ESG Essentials: What You Need To Know Now - Episode 13 - Sustainable Ethos Litigation: Aspiration or Inaction?
A Conversation with Nevada Attorney General Aaron Ford - Regulatory Oversight Podcast
Consumer Protection and Safety and Soundness Perspective of Credit Union Regulation - The Consumer Finance Podcast
A Conversation with Kristi Kelly of Kelly Guzzo - FCRA Focus Podcast
The Current Landscape of Bank-Fintech Partnerships - The Consumer Finance Podcast
FCPA Compliance Report-Episode 470-Quyen Truong on California’s Proposed Mini-CFPB: National Impact and Enforcement Threat
On May 15, 2024, the Federal Trade Commission Chair Lina M. Khan appeared before the House Appropriations Subcommittee on Financial Services and General Government to discuss the agency’s FY 2025 budget request and ongoing...more
With growing concerns related to how artificial intelligence is developed, regulated, and implemented in the United States, this Executive Order represents possibly the first of several governmental actions to address this...more
The No Surprises Act (NSA) has been in effect since January 2022, and has faced litigation ever since from healthcare providers. States and federal agencies are also examining surprise billing and consumer protection laws...more
Over the past year, the Federal Trade Commission (FTC) has emerged as a leading actor in the health privacy enforcement space, spearheading enforcement actions, policy statements, and regulatory changes all aimed at...more
Enacted as Division BB of the Consolidated Appropriations Act, 2021, the No Surprises Act (NSA) provides federal protections against surprise billing with respect to: - Emergency services (including post-stabilization...more
COVID-19- Bipartisan Group of Attorneys General Seeks to Expand Production of Antiviral Drug- A bipartisan group of 34 AGs, led by California AG Xavier Becerra and Louisiana AG Jeff Landry, sent a letter urging the U.S....more
LEGISLATION, REGULATIONS & STANDARDS - FDA Lifts Import Alert on GE Salmon - The U.S. Food and Drug Administration (FDA) has deactivated an import alert that prevented the introduction of genetically engineered (GE)...more
Senators Call For Removal of Dioxane from Cosmetic Products - U.S. Sens. Chuck Schumer (DN. Y.) and Kirsten Gillibrand (DN. Y.) have petitioned the Food and Drug Administration to prohibit detectable levels of 1,4dioxane...more